AI 聊天
Loading data for WAT — first visit, this takes a few seconds.

Waters Corporation

WAT · NYSE · USD

410.01 +1.67 (0.41%)

收盤價: Sep 15, 2026, 3:59 PM

市值
$40.95B
下次財報日期
Oct 30, 2026

Waters Corporation(WAT)股價、分析與資料

內在價值

正在載入內在價值…

分析師預測

股票預測 →

分析師預測無法取得

12個月目標價 · n/a 位分析師

分析師共識: n/a

間隔:1D
正在載入K線和訊號…

財務表現

查看財務 →

正在載入...

最新財報

已通報較預期YoY 變更
營收$1.65Bn/a+113.36%
EPS$3.05+$0.04+3.39%

下次財報

開盤前。

估計 · 升級 →

查看財報詳情 →

指標

買價
407.73
市值
41B
淨利(ttm)
167M
1.19
4
104.27
25.21
P/B (ttm)
2.70
P/S (ttm)
8.82
財報日期
Oct 30, 2026
賣價
408.17
成交量
728,750
20 日平均成交量
824,516
開盤價
411.66
前收盤價
408.34
當日區間
402.12 - 411.66
52 週範圍
282.77 - 426.22
股利
n/a
除息日
Nov 26, 1996

關於 Waters Corporation

查看公司資料 →
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts. Diagnostics & Research · Healthcare

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

類股 Healthcare
IPO 日期 Nov 17, 1995
員工 16,000
證券交易所 NYSE
股票代號 WAT